REQUEST A DEMO
Total
USD $0.00
Search more companies

Tmc Life Sciences Berhad (Malaysia)

Main Activities: Ambulatory Health Care Services | Management of Companies and Enterprises
Full name: Tmc Life Sciences Berhad Profile Updated: October 06, 2019
Buy our report for this company USD 29.95 Most recent financial data: 2019 Available in: English Download a sample report

Tmc Life Sciences Berhad operates as an investment holding company. The subsidiaries provide business consultancy services, the operation of women’s clinic. The services include the provision of storage of cord blood and adult stem cells, stem cell therapy as well as the research and development services on related products. The company was incorporated in 2003 and is based in Shah Alam.

Legal Address
C-13-09 Sunway Nexis,No.1 Jalan Pju 5/1,Dataran Sunway
Petaling Jaya; Selangor; Postal Code: 47810

Contact Details: Purchase the Tmc Life Sciences Berhad report to view the information.

Basic Information
Total Employees:
Purchase the Tmc Life Sciences Berhad report to view the information.
Outstanding Shares:
Purchase the Tmc Life Sciences Berhad report to view the information.
Financial Auditors:
Purchase the Tmc Life Sciences Berhad report to view the information.
Incorporation Date:
2003
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Board Of Directors
Ownership Details
Purchase this report to view the information.
7.64%
Subsidiaries
IVF Technologies Sdn. Bhd.
100%
Stemtech International Sdn. Bhd.
100%
TMC Biotech Sdn. Bhd.
100%
Company Performance
Financial values in the chart are available after Tmc Life Sciences Berhad report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
11.39%
Total operating revenue
11.44%
Operating profit (EBIT)
24.79%
EBITDA
-51.53%
Net Profit (Loss) for the Period
12.49%
Total assets
8.87%
Total equity
3.05%
Operating Profit Margin (ROS)
1.91%
Net Profit Margin
0.15%
Return on Equity (ROE)
0.08%
Debt to Equity Ratio
0.92%
Quick Ratio
-3.04%
Cash Ratio
-2.64%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?